Document is current
Any future updates will be listed below
-
Authors
Bartlett, Edmund K. https://orcid.org/0000-0002-0923-153X
Kalvin, Hannah L.
Barker, Christopher A.
Ariyan, Charlotte E.
Brady, Mary Sue
Bello, Danielle M.
Kelly, Ciara M.
Chen, Joyce M.
Busam, Klaus J.
Panageas, Katherine S.
Coit, Daniel G.
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 25 August 2025
Accepted: 11 November 2025
First Online: 25 November 2025
Disclosure
: EKB has received research funding via the institution from SkylineDx and QBiotics Group; provided consulting/advisory services for QBiotics Group; CEA has provided consulting/advisory services for Iovance Biotherapeutics, Merck & Co., and Merck KgaA. CAB has provided consulting/advisory services for Regeneron. CMK has received research funding via the institution from Amgen, curadev, IDRx, Inhibrx, Merck, Regeneron, and Servier; provided consulting/advisory services for Daiichi Sankyo; and has a spouse employed by Daiichi Sankyo. No other authors have relationships with outside entities to disclose.
